Effect of levodopa on handwriting tasks of different complexity in Parkinson's disease: a kinematic study

被引:8
|
作者
Zham, Poonam [1 ]
Kumar, Dinesh [1 ]
Viswanthan, Rekha [1 ]
Wong, Kit [2 ]
Nagao, Kanae J. [2 ]
Arjunan, Sridhar Poosapadi [1 ]
Raghav, Sanjay [1 ,2 ]
Kempster, Peter [2 ]
机构
[1] RMIT Univ, Sch Engn, Melbourne, Vic 3000, Australia
[2] Monash Med Ctr, Melbourne, Vic, Australia
关键词
Parkinson's disease; Levodopa; Kinematic; Dysgraphia; BASAL GANGLIA; MICROGRAPHIA; IMPAIRMENT; TOOL;
D O I
10.1007/s00415-019-09268-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Levodopa treatment does improve Parkinson's disease (PD) dysgraphia, but previous research is not in agreement about which aspects are most responsive. This study investigated the effect of levodopa on the kinematics of writing. Twenty-four patients with PD of less than 10years duration and 25 age-matched controls were recruited. A practically defined off state method was used to assess the levodopa motor response, measured on the Unified Parkinson's Disease Rating Scale PartIII. The kinematic features for six handwriting tasks involving different levels of complexity were recorded from PD patients in off and on states and from the control group. Levodopa is effective for simple writing activities involving repetition of letters, denoting improved fine motor control. But the same benefit was not seen for copying a sentence and a written category fluency test, tasks that carry memory and cognitive loads. We also found significant differences in kinematic features between control participants and PD patients, for all tasks and in both on and off states. Serial testing of handwriting in patients known to be at risk for developing PD might prove to be an effective biomarker for cell loss in the substantia nigra and the associated dopamine deficiency. We recommend using a panel of writing tasks including sentence copying and memory dependence. Dual-task effects may make these activities more sensitive to early motor deficits, while their weaker levodopa responsiveness would cause them to be more stable indicators of motor progression once symptomatic treatment has been commenced.
引用
收藏
页码:1376 / 1382
页数:7
相关论文
共 50 条
  • [41] The effect of dextromethorphan on levodopa associated dyskinesias in Parkinson's disease
    Metman, LV
    Blanchet, PJ
    Natte, R
    Mouradian, MM
    Chase, TN
    NEUROLOGY, 1997, 48 (03) : 5137 - 5137
  • [42] Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease
    Palacios, Natalia
    Hannoun, Anas
    Flahive, Julie
    Ward, Doyle
    Goostrey, Kelsey
    Deb, Anindita
    Smith, Kara M.
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [43] Effect of Levodopa on gut microbiome in Parkinson's Disease (PD)
    Hannoun, A.
    Ward, D.
    Flahive, J.
    Friedman, J.
    Deb, A.
    Smith, K.
    MOVEMENT DISORDERS, 2019, 34 : S358 - S359
  • [44] For better or worse: The effect of levodopa on speech in Parkinson's disease
    Ho, Aileen K.
    Bradshaw, John L.
    Iansek, Robert
    MOVEMENT DISORDERS, 2008, 23 (04) : 574 - 580
  • [45] Levodopa effect on experimental pain in Parkinson's disease: A clinical and neuroimaging pilot study
    Brefel-Courbon, C
    Payoux, P
    Quelven, I
    Claire, T
    Galitzky, M
    Montastruc, JL
    MOVEMENT DISORDERS, 2002, 17 : S46 - S46
  • [46] Study on the effect of levodopa administration on serum zinc levels in Parkinson's disease patients
    Matsuyama, H.
    Matsuura, K.
    Ishikawa, H.
    Hirata, Y.
    Kato, N.
    Niwa, A.
    Narita, Y.
    Tomimoto, H.
    MOVEMENT DISORDERS, 2019, 34 : S290 - S290
  • [47] Different kinematic strategies in handwriting in writer's cramp
    Balas, M
    Gruendlinger, L
    Karni, A
    Giladi, N
    MOVEMENT DISORDERS, 2005, 20 : S26 - S26
  • [48] A Kinematic Study of Progressive Micrographia in Parkinson's Disease
    Zham, Poonam
    Raghay, Sanjay
    Kempster, Peter
    Arjunan, Sridhar Poosapadi
    Wong, Kit
    Nagao, Kanae J.
    Kumar, Dinesh K.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [49] Levodopa for Parkinson's Disease.
    Devos, David
    Moreau, Caroline
    Destee, Alain
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (09): : 935 - 936
  • [50] Levodopa in the treatment of Parkinson's disease
    Schapira, A. H. V.
    Emre, M.
    Jenner, P.
    Poewe, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (09) : 982 - 989